Cite
HARVARD Citation
Turnic, T. et al. (2022). Bradykinin and Galectin-3 in Survived and Deceased Patients with COVID-19 Pneumonia: An Increasingly Promising Biochemical Target. Oxidative medicine and cellular longevity. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Turnic, T. et al. (2022). Bradykinin and Galectin-3 in Survived and Deceased Patients with COVID-19 Pneumonia: An Increasingly Promising Biochemical Target. Oxidative medicine and cellular longevity. p. . [Online].